ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

University College London Hospitals at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

University College London Hospitals takes part in 8 sessions at ESMO 2026 in Madrid. Its work spans cancer treatment and supportive care across breast, gastrointestinal, gynaecological and other cancers. It examines biodegradable microneedles loaded with silica nanoparticles to deliver doxorubicin locally.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
NHS foundation trust running teaching hospitals in central London, United Kingdom, linked to University College London.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Physician perspectives on defining cure in early-stage melanoma
ePoster session 11
Melanoma & skin cancers
Poster
Fri Oct 23
13:00–15:00
Chair
Fri Oct 23
16:15–17:45
Beyond traditional therapy: The impact of emerging approaches on sarcoma treatment
with Centre Léon Bérard
Sarcoma, CNS, head & neck and rare cancers
Talk
Fri Oct 23
17:15–17:35
Predictive signatures in sarcomas with "damaged" DNA: A matter of caution or excitement?
Beyond traditional therapy: The impact of emerging approaches on sarcoma treatment
Sarcoma, CNS, head & neck and rare cancers
Chair
Sat Oct 24
14:45–16:15
Rapid oral: Gastrointestinal tumours, lower digestive
with Università Cattolica del Sacro Cuore, Memorial Sloan Kettering Cancer Center
Gastrointestinal cancers
Abstract
Sat Oct 24
15:47–15:59
Invited Discussant LBA31 and LBA32
Rapid oral: Gastrointestinal tumours, lower digestive
Gastrointestinal cancers
Chair
Sun Oct 25
10:15–11:45
Rapid oral: Melanoma and other skin tumours
with Institut Strauss, University Medical Center Hamburg-Eppendorf
Melanoma & skin cancers
Abstract
Sun Oct 25
10:57–11:09
Invited Discussant LBA59, LBA60 and 2486RO
Rapid oral: Melanoma and other skin tumours
Melanoma & skin cancers
Poster
Mon Oct 26
12:00–12:45
Satellite
Mon Oct 26
13:20–13:40
Clinical Scenario 1: Progression Following Prior Therapy
Takeda - mCRC Borderless Tumor Board: Navigating real-world treatment decisions in chemorefractory mCRC
Gastrointestinal cancers
Satellite
Mon Oct 26
13:40–14:00
Clinical Scenario 2: Patient with Treatment Related Toxicities
Takeda - mCRC Borderless Tumor Board: Navigating real-world treatment decisions in chemorefractory mCRC
Gastrointestinal cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University College London Hospitals

Tell us what you sell and we’ll find the people at University College London Hospitals most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction